Europe Finance Weekly
SEE OTHER BRANDS

Fresh finance and banking news from Europe

Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on May 8, 2025

Allbirds Reports First Quarter 2025 Financial Results

Allbirds Reports First Quarter 2025 Financial Results

Delivers First Quarter Results in Line with and Above Guidance Ranges Reiterates Full Year 2025 Outlook and Provides Second Quarter 2025 Guidance SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that …

Leslie’s, Inc. Announces Second Quarter Fiscal 2025 Financial Results; Re-Affirms Full Year Guidance

Leslie’s, Inc. Announces Second Quarter Fiscal 2025 Financial Results; Re-Affirms Full Year Guidance

PHOENIX, May 08, 2025 (GLOBE NEWSWIRE) -- Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced its …

PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program

PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 20% and was 40% of total revenue; CTV revenue grew over 50% year-over-year; and Supply Path Optimization represented a record 55%+ of total …

TTM Technologies, Inc. Announces Retirement of Founder and Board Member, Kent Alder

TTM Technologies, Inc. Announces Retirement of Founder and Board Member, Kent Alder

SANTA ANA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, quick …

Oculis Reports Q1 2025 Financial Results and Provides Company Update

Oculis Reports Q1 2025 Financial Results and Provides Company Update

The recent R…

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

– Ongoing clinical studies for four candidates on track with data expected in 2025, including interim Phase 1b data for long-acting helicase-primase inhibitors ABI-5366 and ABI-1179 anticipated in fall 2025 – – New data from multiple programs highlighted …

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 …

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expected in Q3 2025, with topline data from both 4FRONT-1 and …

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date   CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Sprout Social Announces First Quarter 2025 Financial Results

Sprout Social Announces First Quarter 2025 Financial Results

CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its first quarter ended March …

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric disease and orphan-designated indication, has reached approximately 95% enrollment and is expected to complete enrollment in the second quarter of 2025 …

Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended March 31, 2025 of $0.049 Per Unit

Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended March 31, 2025 of $0.049 Per Unit

ATHENS, Greece, May 08, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a quarterly cash distribution with respect to the …

CarGurus Announces First Quarter 2025 Results

CarGurus Announces First Quarter 2025 Results

Marketplace revenue grew 13% YoY Q1'25 Net Income of $39.0 million; Non-GAAP Adjusted EBITDA of $66.3 million, up 32% YoY Repurchased $184.2 million worth of shares in Q1'25, representing 6% of our outstanding capital BOSTON, May 08, 2025 (GLOBE NEWSWIRE) …

Westrock Coffee Company Reports First Quarter 2025 Results and Reaffirms 2025 and 2026 Outlook

Westrock Coffee Company Reports First Quarter 2025 Results and Reaffirms 2025 and 2026 Outlook

LITTLE ROCK, Ark., May 08, 2025 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the first quarter ended March 31, 2025. First Quarter Highlights1 Consolidated Results Net …

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to June 9, 2025

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to June 9, 2025

New York, NY, May 08, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on May 5, 2025, it caused to be deposited $60,000 ( …

Bridger Aerospace Announces Record First Quarter; Reiterates 2025 Guidance

Bridger Aerospace Announces Record First Quarter; Reiterates 2025 Guidance

BELGRADE, Mont., May 08, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported record results for …

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

Topline data from pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN on track for Q4 2025 Completed enrollment in PROGRESS-AD Phase 2 clinical trial of AL101 in early Alzheimer’s disease Continuing to pursue Alector Brain Carrier programs, …

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025; Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025 Cash runway extending into the third quarter of 2026 with no debt Conference call …

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service